Report Overview
Report Overview
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Second-Generation Antihistamines competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Second-generation antihistamines are a class of drugs that selectively antagonize peripheral H1 receptors, primarily used to treat allergic conditions such as allergic rhinitis and urticaria. Compared with first-generation antihistamines, they exhibit lower penetration into the central nervous system, resulting in significantly reduced sedative and drowsiness effects. They are characterized by rapid onset and long duration of action, making them commonly used non-sedating anti-allergy agents in clinical practice. In 2024, the global sales volume of second-generation antihistamines was 195 million boxes, with an average price of USD 14.5 per box.
The global Second-Generation Antihistamines market size was estimated at USD 2815.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Second-Generation Antihistamines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Second-Generation Antihistamines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Second-Generation Antihistamines market.
Global Second-Generation Antihistamines Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Sanofi
Bayer
Novartis
Johnson & Johnson
UCB Pharma
Faes Farma
Teva
Pfizer
Chia Tai Tianqing
Yangtze River Pharma
Hainan Huahai Pharma
Hengrui Medicine
CSPC Pharmaceutical
Qilu Pharmaceutical
Guangzhou Baiyunshan
Taiji Group
Proya Pharma
Market Segmentation (by Type)
Cetirizine
Levocetirizine
Loratadine
Desloratadine
Fexofenadine
Bilastine
Rupatadine
Market Segmentation (by Application)
Allergic Rhinitis
Urticaria
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Second-Generation Antihistamines Market
Overview of the regional outlook of the Second-Generation Antihistamines Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Second-Generation Antihistamines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Second-Generation Antihistamines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Second-Generation Antihistamines
- 1.2 Key Market Segments
- 1.2.1 Second-Generation Antihistamines Segment by Type
- 1.2.2 Second-Generation Antihistamines Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Second-Generation Antihistamines Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Second-Generation Antihistamines Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Second-Generation Antihistamines Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Second-Generation Antihistamines Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Second-Generation Antihistamines Product Life Cycle
- 3.3 Global Second-Generation Antihistamines Sales by Manufacturers (2020-2025)
- 3.4 Global Second-Generation Antihistamines Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Second-Generation Antihistamines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Second-Generation Antihistamines Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Second-Generation Antihistamines Market Competitive Situation and Trends
- 3.8.1 Second-Generation Antihistamines Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Second-Generation Antihistamines Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Second-Generation Antihistamines Industry Chain Analysis
- 4.1 Second-Generation Antihistamines Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Second-Generation Antihistamines Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Second-Generation Antihistamines Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Second-Generation Antihistamines Market
- 5.7 ESG Ratings of Leading Companies
- 6 Second-Generation Antihistamines Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Second-Generation Antihistamines Sales Market Share by Type (2020-2025)
- 6.3 Global Second-Generation Antihistamines Market Size by Type (2020-2025)
- 6.4 Global Second-Generation Antihistamines Price by Type (2020-2025)
- 7 Second-Generation Antihistamines Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Second-Generation Antihistamines Market Sales by Application (2020-2025)
- 7.3 Global Second-Generation Antihistamines Market Size (M USD) by Application (2020-2025)
- 7.4 Global Second-Generation Antihistamines Sales Growth Rate by Application (2020-2025)
- 8 Second-Generation Antihistamines Market Sales by Region
- 8.1 Global Second-Generation Antihistamines Sales by Region
- 8.1.1 Global Second-Generation Antihistamines Sales by Region
- 8.1.2 Global Second-Generation Antihistamines Sales Market Share by Region
- 8.2 Global Second-Generation Antihistamines Market Size by Region
- 8.2.1 Global Second-Generation Antihistamines Market Size by Region
- 8.2.2 Global Second-Generation Antihistamines Market Size by Region
- 8.3 North America
- 8.3.1 North America Second-Generation Antihistamines Sales by Country
- 8.3.2 North America Second-Generation Antihistamines Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Second-Generation Antihistamines Sales by Country
- 8.4.2 Europe Second-Generation Antihistamines Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Second-Generation Antihistamines Sales by Region
- 8.5.2 Asia Pacific Second-Generation Antihistamines Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Second-Generation Antihistamines Sales by Country
- 8.6.2 South America Second-Generation Antihistamines Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Second-Generation Antihistamines Sales by Region
- 8.7.2 Middle East and Africa Second-Generation Antihistamines Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Second-Generation Antihistamines Sales by Region
- 9 Second-Generation Antihistamines Market Production by Region
- 9.1 Global Production of Second-Generation Antihistamines by Region(2020-2025)
- 9.2 Global Second-Generation Antihistamines Revenue Market Share by Region (2020-2025)
- 9.3 Global Second-Generation Antihistamines Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Second-Generation Antihistamines Production
- 9.4.1 North America Second-Generation Antihistamines Production Growth Rate (2020-2025)
- 9.4.2 North America Second-Generation Antihistamines Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Second-Generation Antihistamines Production
- 9.5.1 Europe Second-Generation Antihistamines Production Growth Rate (2020-2025)
- 9.5.2 Europe Second-Generation Antihistamines Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Second-Generation Antihistamines Production (2020-2025)
- 9.6.1 Japan Second-Generation Antihistamines Production Growth Rate (2020-2025)
- 9.6.2 Japan Second-Generation Antihistamines Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Second-Generation Antihistamines Production (2020-2025)
- 9.7.1 China Second-Generation Antihistamines Production Growth Rate (2020-2025)
- 9.7.2 China Second-Generation Antihistamines Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Sanofi
- 10.1.1 Sanofi Basic Information
- 10.1.2 Sanofi Second-Generation Antihistamines Product Overview
- 10.1.3 Sanofi Second-Generation Antihistamines Product Market Performance
- 10.1.4 Sanofi Business Overview
- 10.1.5 Sanofi SWOT Analysis
- 10.1.6 Sanofi Recent Developments
- 10.2 Bayer
- 10.2.1 Bayer Basic Information
- 10.2.2 Bayer Second-Generation Antihistamines Product Overview
- 10.2.3 Bayer Second-Generation Antihistamines Product Market Performance
- 10.2.4 Bayer Business Overview
- 10.2.5 Bayer SWOT Analysis
- 10.2.6 Bayer Recent Developments
- 10.3 Novartis
- 10.3.1 Novartis Basic Information
- 10.3.2 Novartis Second-Generation Antihistamines Product Overview
- 10.3.3 Novartis Second-Generation Antihistamines Product Market Performance
- 10.3.4 Novartis Business Overview
- 10.3.5 Novartis SWOT Analysis
- 10.3.6 Novartis Recent Developments
- 10.4 Johnson and Johnson
- 10.4.1 Johnson and Johnson Basic Information
- 10.4.2 Johnson and Johnson Second-Generation Antihistamines Product Overview
- 10.4.3 Johnson and Johnson Second-Generation Antihistamines Product Market Performance
- 10.4.4 Johnson and Johnson Business Overview
- 10.4.5 Johnson and Johnson Recent Developments
- 10.5 UCB Pharma
- 10.5.1 UCB Pharma Basic Information
- 10.5.2 UCB Pharma Second-Generation Antihistamines Product Overview
- 10.5.3 UCB Pharma Second-Generation Antihistamines Product Market Performance
- 10.5.4 UCB Pharma Business Overview
- 10.5.5 UCB Pharma Recent Developments
- 10.6 Faes Farma
- 10.6.1 Faes Farma Basic Information
- 10.6.2 Faes Farma Second-Generation Antihistamines Product Overview
- 10.6.3 Faes Farma Second-Generation Antihistamines Product Market Performance
- 10.6.4 Faes Farma Business Overview
- 10.6.5 Faes Farma Recent Developments
- 10.7 Teva
- 10.7.1 Teva Basic Information
- 10.7.2 Teva Second-Generation Antihistamines Product Overview
- 10.7.3 Teva Second-Generation Antihistamines Product Market Performance
- 10.7.4 Teva Business Overview
- 10.7.5 Teva Recent Developments
- 10.8 Pfizer
- 10.8.1 Pfizer Basic Information
- 10.8.2 Pfizer Second-Generation Antihistamines Product Overview
- 10.8.3 Pfizer Second-Generation Antihistamines Product Market Performance
- 10.8.4 Pfizer Business Overview
- 10.8.5 Pfizer Recent Developments
- 10.9 Chia Tai Tianqing
- 10.9.1 Chia Tai Tianqing Basic Information
- 10.9.2 Chia Tai Tianqing Second-Generation Antihistamines Product Overview
- 10.9.3 Chia Tai Tianqing Second-Generation Antihistamines Product Market Performance
- 10.9.4 Chia Tai Tianqing Business Overview
- 10.9.5 Chia Tai Tianqing Recent Developments
- 10.10 Yangtze River Pharma
- 10.10.1 Yangtze River Pharma Basic Information
- 10.10.2 Yangtze River Pharma Second-Generation Antihistamines Product Overview
- 10.10.3 Yangtze River Pharma Second-Generation Antihistamines Product Market Performance
- 10.10.4 Yangtze River Pharma Business Overview
- 10.10.5 Yangtze River Pharma Recent Developments
- 10.11 Hainan Huahai Pharma
- 10.11.1 Hainan Huahai Pharma Basic Information
- 10.11.2 Hainan Huahai Pharma Second-Generation Antihistamines Product Overview
- 10.11.3 Hainan Huahai Pharma Second-Generation Antihistamines Product Market Performance
- 10.11.4 Hainan Huahai Pharma Business Overview
- 10.11.5 Hainan Huahai Pharma Recent Developments
- 10.12 Hengrui Medicine
- 10.12.1 Hengrui Medicine Basic Information
- 10.12.2 Hengrui Medicine Second-Generation Antihistamines Product Overview
- 10.12.3 Hengrui Medicine Second-Generation Antihistamines Product Market Performance
- 10.12.4 Hengrui Medicine Business Overview
- 10.12.5 Hengrui Medicine Recent Developments
- 10.13 CSPC Pharmaceutical
- 10.13.1 CSPC Pharmaceutical Basic Information
- 10.13.2 CSPC Pharmaceutical Second-Generation Antihistamines Product Overview
- 10.13.3 CSPC Pharmaceutical Second-Generation Antihistamines Product Market Performance
- 10.13.4 CSPC Pharmaceutical Business Overview
- 10.13.5 CSPC Pharmaceutical Recent Developments
- 10.14 Qilu Pharmaceutical
- 10.14.1 Qilu Pharmaceutical Basic Information
- 10.14.2 Qilu Pharmaceutical Second-Generation Antihistamines Product Overview
- 10.14.3 Qilu Pharmaceutical Second-Generation Antihistamines Product Market Performance
- 10.14.4 Qilu Pharmaceutical Business Overview
- 10.14.5 Qilu Pharmaceutical Recent Developments
- 10.15 Guangzhou Baiyunshan
- 10.15.1 Guangzhou Baiyunshan Basic Information
- 10.15.2 Guangzhou Baiyunshan Second-Generation Antihistamines Product Overview
- 10.15.3 Guangzhou Baiyunshan Second-Generation Antihistamines Product Market Performance
- 10.15.4 Guangzhou Baiyunshan Business Overview
- 10.15.5 Guangzhou Baiyunshan Recent Developments
- 10.16 Taiji Group
- 10.16.1 Taiji Group Basic Information
- 10.16.2 Taiji Group Second-Generation Antihistamines Product Overview
- 10.16.3 Taiji Group Second-Generation Antihistamines Product Market Performance
- 10.16.4 Taiji Group Business Overview
- 10.16.5 Taiji Group Recent Developments
- 10.17 Proya Pharma
- 10.17.1 Proya Pharma Basic Information
- 10.17.2 Proya Pharma Second-Generation Antihistamines Product Overview
- 10.17.3 Proya Pharma Second-Generation Antihistamines Product Market Performance
- 10.17.4 Proya Pharma Business Overview
- 10.17.5 Proya Pharma Recent Developments
- 10.1 Sanofi
- 11 Second-Generation Antihistamines Market Forecast by Region
- 11.1 Global Second-Generation Antihistamines Market Size Forecast
- 11.2 Global Second-Generation Antihistamines Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Second-Generation Antihistamines Market Size Forecast by Country
- 11.2.3 Asia Pacific Second-Generation Antihistamines Market Size Forecast by Region
- 11.2.4 South America Second-Generation Antihistamines Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Second-Generation Antihistamines by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Second-Generation Antihistamines Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Second-Generation Antihistamines by Type (2026-2035)
- 12.1.2 Global Second-Generation Antihistamines Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Second-Generation Antihistamines by Type (2026-2035)
- 12.2 Global Second-Generation Antihistamines Market Forecast by Application (2026-2035)
- 12.2.1 Global Second-Generation Antihistamines Sales (K MT) Forecast by Application
- 12.2.2 Global Second-Generation Antihistamines Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Second-Generation Antihistamines Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings